Curcumin alleviates neuropathic pain by inhibiting p300/CBP histone acetyltransferase activity-regulated expression of BDNF and cox-2 in a rat model.
The management of neuropathic pain is still a major challenge because of its unresponsiveness to most common treatments. Curcumin has been reported to play an active role in the treatment of various neurological disorders, such as neuropathic pain. Curcumin has long been recognized as a p300/CREB-bi...
Guardado en:
Autores principales: | Xiaoyan Zhu, Qian Li, Ruimin Chang, Dong Yang, Zongbing Song, Qulian Guo, Changsheng Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d18fb07ad16944b19566bb58867776e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
E2F1 acetylation directs p300/CBP-mediated histone acetylation at DNA double-strand breaks to facilitate repair
por: Swarnalatha Manickavinayaham, et al.
Publicado: (2019) -
Dihydromyricetin affects BDNF levels in the nervous system in rats with comorbid diabetic neuropathic pain and depression
por: Huixiang Ge, et al.
Publicado: (2019) -
Short-chain fatty acids activate acetyltransferase p300
por: Sydney P Thomas, et al.
Publicado: (2021) -
Transcription coactivators p300 and CBP are necessary for photoreceptor-specific chromatin organization and gene expression.
por: Anne K Hennig, et al.
Publicado: (2013) -
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function
por: Manish Kumar, et al.
Publicado: (2021)